{"success":true,"data":{"pressRelease":{"id":"83694","rtpr_id":"nGNX15CFbc","ticker":"CRNX","exchange":"NASDAQ","all_tickers":["CRNX","ESI","INVE","SLP"],"title":"Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders","author":"Globe Newswire","published_at":"2026-07-08T18:35:39.112Z","article_body":"Insiders may stand to receive substantial financial benefits not available to\nordinary shareholders. \n\nThe proposed transactions may contain terms that could limit superior\ncompeting offers.\n\nShareholders are encouraged to contact the firm to discuss their rights and\noptions at no cost or obligation. We would handle any matter on a contingent\nfee basis, whereby you would not be responsible for out-of-pocket payment of\nour legal fees or expenses.\n\nNEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor\nrights law firm, is investigating the following companies for potential\nviolations of the federal securities laws and/or breaches of fiduciary duties\nto shareholders relating to:\n\nCrinetics Pharmaceuticals, Inc. (NASDAQ: CRNX)’s sale to Vertex\nPharmaceuticals Incorporated for $85.00 per share in cash. If you are a\nCrinetics shareholder, click here to learn more about your legal rights and\noptions\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwUS3a61hdP2o40ctA9FdX0Vq4MFfzT3ks4vgGblrSucuMloQXCpCEimnOIz9AMJfHzA_dL7PfOgttpNr_P-784ga2Q6bUnADAAz4Olo3h_wKlnTSNXt3AVN150hRVUvEV53tjrDFTZVtVCg83O9WbXWD0o14UGrN9HoeIGaUqlHGNQ==).\n\nElement Solutions Inc (NYSE: ESI)’s sale to Solstice Advanced Materials,\nInc. for $10.00 in cash and 0.500 shares of Solstice common stock for each\nElement share. Upon closing of the Proposed Transaction, Element shareholders\nare expected to own approximately 44% of the combined company. If you are an\nElement shareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwURA05h3UWXZL6394kTEVfR7qICoY9zZvooDhFJ7SMgYflv9UbWjCzVskJVHNIjTENlUqJeiGtttN-1WGhjzRraPknxhk2npGemCDgnVLuHgG48O20QAJRjRuDI4h04Gg40hBCGHT5LxetdfoK4lz2Uw).\n\nIdentiv, Inc.’s (NASDAQ: INVE)’s sale of its IoT business operating\nassets and its Thai subsidiary to Trackonomy Systems, Inc. If you are an\nIdentiv shareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwURA05h3UWXZL6394kTEVfR7qICoY9zZvooDhFJ7SMgYfvhYjTn3_WJ8GMJT2fDuwf3XwUa7uw8ehEXFp3RxCNJWEGb9o5Na2MHJKy1Z64cv0awIWWbbKLs7kk0d4aLZm1A=).\n\nSimulations Plus, Inc. (NASDAQ: SLP)’s sale to affiliates of Altaris, LLC\nfor $18.50 per share. If you are a Simulations shareholder, click here to\nlearn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwURA05h3UWXZL6394kTEVfR7qICoY9zZvooDhFJ7SMgYfhR28c-eK8ydxNvS_PfavdmSfUsTvSeF5Xri7-cLXMUSpFl-uzNkEEIJ7woArhZS6dK7YrHXby5Nj73glSQBRVe6s9rhU8EzrlYT1u6yRP1L).\n\nOn behalf of shareholders, Halper Sadeh LLC may seek increased consideration,\nadditional disclosures and information, or other relief and benefits.\n\nHalper Sadeh LLC represents investors all over the world who have fallen\nvictim to securities fraud and corporate misconduct. Our attorneys have been\ninstrumental in implementing corporate reforms and recovering millions of\ndollars on behalf of defrauded investors.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\nHalper Sadeh LLC\nDaniel Sadeh, Esq.\nZachary Halper, Esq.\nOne World Trade Center\n85th Floor\nNew York, NY 10007\n(212) 763-0060\nsadeh@halpersadeh.com\nzhalper@halpersadeh.com   \nhttps://www.halpersadeh.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX15CFbc","title":"Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders","author":"Globe Newswire","ticker":"CRNX","created":"2026-07-08T18:35:39.112Z","tickers":["CRNX","ESI","INVE","SLP"],"exchange":"NASDAQ","article_body":"Insiders may stand to receive substantial financial benefits not available to\nordinary shareholders. \n\nThe proposed transactions may contain terms that could limit superior\ncompeting offers.\n\nShareholders are encouraged to contact the firm to discuss their rights and\noptions at no cost or obligation. We would handle any matter on a contingent\nfee basis, whereby you would not be responsible for out-of-pocket payment of\nour legal fees or expenses.\n\nNEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor\nrights law firm, is investigating the following companies for potential\nviolations of the federal securities laws and/or breaches of fiduciary duties\nto shareholders relating to:\n\nCrinetics Pharmaceuticals, Inc. (NASDAQ: CRNX)’s sale to Vertex\nPharmaceuticals Incorporated for $85.00 per share in cash. If you are a\nCrinetics shareholder, click here to learn more about your legal rights and\noptions\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwUS3a61hdP2o40ctA9FdX0Vq4MFfzT3ks4vgGblrSucuMloQXCpCEimnOIz9AMJfHzA_dL7PfOgttpNr_P-784ga2Q6bUnADAAz4Olo3h_wKlnTSNXt3AVN150hRVUvEV53tjrDFTZVtVCg83O9WbXWD0o14UGrN9HoeIGaUqlHGNQ==).\n\nElement Solutions Inc (NYSE: ESI)’s sale to Solstice Advanced Materials,\nInc. for $10.00 in cash and 0.500 shares of Solstice common stock for each\nElement share. Upon closing of the Proposed Transaction, Element shareholders\nare expected to own approximately 44% of the combined company. If you are an\nElement shareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwURA05h3UWXZL6394kTEVfR7qICoY9zZvooDhFJ7SMgYflv9UbWjCzVskJVHNIjTENlUqJeiGtttN-1WGhjzRraPknxhk2npGemCDgnVLuHgG48O20QAJRjRuDI4h04Gg40hBCGHT5LxetdfoK4lz2Uw).\n\nIdentiv, Inc.’s (NASDAQ: INVE)’s sale of its IoT business operating\nassets and its Thai subsidiary to Trackonomy Systems, Inc. If you are an\nIdentiv shareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwURA05h3UWXZL6394kTEVfR7qICoY9zZvooDhFJ7SMgYfvhYjTn3_WJ8GMJT2fDuwf3XwUa7uw8ehEXFp3RxCNJWEGb9o5Na2MHJKy1Z64cv0awIWWbbKLs7kk0d4aLZm1A=).\n\nSimulations Plus, Inc. (NASDAQ: SLP)’s sale to affiliates of Altaris, LLC\nfor $18.50 per share. If you are a Simulations shareholder, click here to\nlearn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=LAbPAW9XCUoIoxm2YGemBreh6it-fOsxPj9D5vdnwURA05h3UWXZL6394kTEVfR7qICoY9zZvooDhFJ7SMgYfhR28c-eK8ydxNvS_PfavdmSfUsTvSeF5Xri7-cLXMUSpFl-uzNkEEIJ7woArhZS6dK7YrHXby5Nj73glSQBRVe6s9rhU8EzrlYT1u6yRP1L).\n\nOn behalf of shareholders, Halper Sadeh LLC may seek increased consideration,\nadditional disclosures and information, or other relief and benefits.\n\nHalper Sadeh LLC represents investors all over the world who have fallen\nvictim to securities fraud and corporate misconduct. Our attorneys have been\ninstrumental in implementing corporate reforms and recovering millions of\ndollars on behalf of defrauded investors.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\nHalper Sadeh LLC\nDaniel Sadeh, Esq.\nZachary Halper, Esq.\nOne World Trade Center\n85th Floor\nNew York, NY 10007\n(212) 763-0060\nsadeh@halpersadeh.com\nzhalper@halpersadeh.com   \nhttps://www.halpersadeh.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-07-08T18:35:39.160383232Z","server_sent_at_ms":1783535739160},"received_at":"2026-07-08T18:35:39.226Z","source_url":null},"analysis":{"id":"72754","press_release_id":"83694","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Halper Sadeh LLC is investigating the board of Crinetics Pharmaceuticals regarding the proposed sale to Vertex Pharmaceuticals for $85.00 per share in cash.\n\nThe investigation concerns potential violations of federal securities laws or breaches of fiduciary duties related to the transaction terms.\n\nShareholders are encouraged to contact the law firm to discuss their rights and options on a contingent fee basis.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{"customDimensions":{"esi_deal_stock_ratio":0.5,"esi_deal_cash_per_share":10,"slp_deal_price_per_share":18.5,"crnx_deal_price_per_share":85}},"quotedText":"Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.","namedEntities":{"people":[{"name":"Daniel Sadeh","role":"Attorney"},{"name":"Zachary Halper","role":"Attorney"}],"products":[],"companies":[{"name":"Halper Sadeh LLC","relationship":"plaintiff law firm"},{"name":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX"},{"name":"Vertex Pharmaceuticals Incorporated","relationship":"acquirer"},{"name":"Element Solutions Inc","ticker":"ESI","relationship":"subject of investigation"},{"name":"Solstice Advanced Materials, Inc.","relationship":"acquirer"},{"name":"Identiv, Inc.","ticker":"INVE","relationship":"subject of investigation"},{"name":"Trackonomy Systems, Inc.","relationship":"acquirer"},{"name":"Simulations Plus, Inc.","ticker":"SLP","relationship":"subject of investigation"},{"name":"Altaris, LLC","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$85.00 per share","context":"CRNX sale to Vertex Pharmaceuticals"},{"amount":"$10.00 in cash","context":"ESI sale to Solstice Advanced Materials"},{"amount":"$18.50 per share","context":"SLP sale to affiliates of Altaris"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Halper Sadeh LLC. No new disclosure from the issuer; no certified class or settlement announced. Standard investigation notice regarding the proposed acquisition."},"tickerRelevance":{"others":[{"ticker":"ESI","relevance":"mentioned subject"},{"ticker":"INVE","relevance":"mentioned subject"},{"ticker":"SLP","relevance":"mentioned subject"}],"primary":"CRNX"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"biotech-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Halper Sadeh LLC is investigating the board of Crinetics Pharmaceuticals regarding the proposed sale to Vertex Pharmaceuticals for $85.00 per share in cash.\n\nThe investigation concerns potential violations of federal securities laws or breaches of fiduciary duties related to the transaction terms.\n\nShareholders are encouraged to contact the law firm to discuss their rights and options on a contingent fee basis.","key_figures":{"customDimensions":{"esi_deal_stock_ratio":0.5,"esi_deal_cash_per_share":10,"slp_deal_price_per_share":18.5,"crnx_deal_price_per_share":85}},"named_entities":{"people":[{"name":"Daniel Sadeh","role":"Attorney"},{"name":"Zachary Halper","role":"Attorney"}],"products":[],"companies":[{"name":"Halper Sadeh LLC","relationship":"plaintiff law firm"},{"name":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX"},{"name":"Vertex Pharmaceuticals Incorporated","relationship":"acquirer"},{"name":"Element Solutions Inc","ticker":"ESI","relationship":"subject of investigation"},{"name":"Solstice Advanced Materials, Inc.","relationship":"acquirer"},{"name":"Identiv, Inc.","ticker":"INVE","relationship":"subject of investigation"},{"name":"Trackonomy Systems, Inc.","relationship":"acquirer"},{"name":"Simulations Plus, Inc.","ticker":"SLP","relationship":"subject of investigation"},{"name":"Altaris, LLC","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$85.00 per share","context":"CRNX sale to Vertex Pharmaceuticals"},{"amount":"$10.00 in cash","context":"ESI sale to Solstice Advanced Materials"},{"amount":"$18.50 per share","context":"SLP sale to affiliates of Altaris"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-08T18:37:30.790Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"biotech-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":null,"modelName":"george-droid-qwen-72b"}}